Skip to main content
OpenTrials

Clinical trial condition

Gonadal Disorders

Explore clinical trials studying Gonadal Disorders. Study availability and eligibility vary by location and protocol.

4,236 public trials 794 recruiting studies
Refine in advanced search Browse all conditions

Gonadal Disorders trial results

Recruiting

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

NCT05983432

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +60 more
Locations
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • City of Hope Cancer Center Duarte, California, United States
  • University of California Irvine Medical Center Orange, California, United States
  • UCLA Santa Monica Santa Monica, California, United States
View all 37 locations
View Trial Details
Recruiting

BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

NCT04752826

Conditions
Adnexal Diseases, Advanced Malignancies, Endocrine Gland Neoplasms, +33 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • Rigshospitalet Copenhagen, Denmark
View all 25 locations
View Trial Details
Recruiting

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

NCT07318558

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Mount Sinai Cancer Center ( Site 0029) Miami Beach, Florida, United States
  • Orlando Health Winnie Palmer Hospital for Women and Babies ( Site 0085) Orlando, Florida, United States
  • Winship Cancer Institute of Emory University ( Site 0037) Atlanta, Georgia, United States
  • Illinois Cancer Specialists (ICS) ( Site 8009) Arlington Heights, Illinois, United States
View all 163 locations
View Trial Details
Recruiting

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

NCT07109726

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +42 more
Locations
  • Florida Cancer Specialists - Lake Nona Orlando, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Mayo Rochester Rochester, Minnesota, United States
  • Washington Univ. School of Medicine St Louis, Missouri, United States
View all 20 locations
View Trial Details
Recruiting

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Crinecerfont in Participants With Classic Congenital Adrenal Hyperplasia (CAH) Who Are Less Than 4 Years Old

NCT07536269

Conditions
Adrenal Gland Diseases, Adrenal Hyperplasia, Congenital, Adrenogenital Syndrome, +16 more
Locations
  • Neurocrine Clinical Site San Francisco, California, United States
  • Neurocrine Clinical Site Hartford, Connecticut, United States
  • Neurocrine Clinical Site Atlanta, Georgia, United States
  • Neurocrine Clinical Site Chicago, Illinois, United States
View Trial Details

Related conditions